Press Release: Statement on FTC challenge to proposed license agreement with Maze Therapeutics health-issue

Press Release: Statement on FTC challenge to proposed license agreement with Maze Therapeutics

Nitesh sinha December 11, 2023

https://ift.tt/eY2VpqD from Sanofi - Aventis Groupe https://ift.tt/qUx9Cjr via IFTTT

Read more
Press Release: Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone health-issue

Press Release: Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone

Nitesh sinha December 10, 2023

https://ift.tt/WhUJOou from Sanofi - Aventis Groupe https://ift.tt/eKjVlJE via IFTTT

Read more
Press Release: Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed multiple myeloma not eligible for transplant health-issue

Press Release: Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed multiple myeloma not eligible for transplant

Nitesh sinha December 07, 2023

https://ift.tt/RnGcMUB Sarclisa ® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed mult…

Read more
Press Release: Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to Industry Leadership in Immunology health-issue

Press Release: Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to Industry Leadership in Immunology

Nitesh sinha December 06, 2023

https://ift.tt/4xvnado R&D Day from Sanofi - Aventis Groupe https://ift.tt/3KMTzsa via IFTTT

Read more
Press Release: Sanofi’s Consumer Healthcare unit launches the Shared Care Collective, an advisory group working to advance sustainability health-issue

Press Release: Sanofi’s Consumer Healthcare unit launches the Shared Care Collective, an advisory group working to advance sustainability

Nitesh sinha November 30, 2023

https://ift.tt/Fv1VqcX Sanofi’s Consumer Healthcare Unit launches the Shared Care Collective, an advisory group working to advance sustainability …

Read more
Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious disease health-issue

Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious disease

Nitesh sinha November 27, 2023

https://ift.tt/ms2h37D Dupixent ® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirm…

Read more
Media Update: Sanofi completes closing for potential first-in-class vaccine against extraintestinal pathogenic E.coli (ExPEC) health-issue

Media Update: Sanofi completes closing for potential first-in-class vaccine against extraintestinal pathogenic E.coli (ExPEC)

Nitesh sinha November 09, 2023

https://ift.tt/aoFfXNw   from Sanofi - Aventis Groupe https://ift.tt/nkCVeNr via IFTTT

Read more